Xpert MTB/RIF Assay Shows Faster Clearance of Mycobacterium tuberculosis DNA with Higher Levels of Rifapentine Exposure

Overview of attention for article published in Journal of Clinical Microbiology, October 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

policy: 2 policy sources
twitter: 5 X users

guideline: 1 clinical guideline source

Readers on

mendeley: 80 Mendeley

So far, Altmetric has seen 4 policy documents that reference this research output.

Сводное руководство ВОЗ по туберкулезу. Модуль 4: лечение. Лечение лекарственно-устойчивого туберкулеза. Пересмотренная редакция 2022 г.

Cited by World Health Organization (WHO) on 27 Jun 2024

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

Сводное руководство ВОЗ по туберкулезу. Модуль 4: лечение. Лечение лекарственно-устойчивого туберкулеза‎

Cited by World Health Organization (WHO) on 01 Jan 2021

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

Сводное руководство воз по лечению лекарственно-устойчивого туберкулеза

Cited by World Health Organization (WHO) on 14 Oct 2019

The World Health Organization (WHO) is the directing and coordinating authority for health within the United Nations system.

TB notes ; 2016, no. 5

Cited by Centers for Disease Control and Prevention (CDC) on 05 Dec 2016

CDC is America’s leading public health agency, dedicated to saving and protecting the health of Americans. CDC monitors health, informs decisionmakers, and provides people with information so they can take responsibility for their own health.

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.